1) Colloid solutions such as plasma expanders maintain blood plasma volume more effectively and efficiently than crystalloid solutions which have a lower molecular weight and only remain in the plasma for a short time.
2) Penicillins and cephalosporins both work by inhibiting bacterial cell wall synthesis. Penicillins block cross-linking via inhibition of transpeptide enzymes while cephalosporins inhibit bacterial cell wall synthesis through inhibition of transpeptide enzymes.
3) Other classes of antibiotics that inhibit cell wall synthesis include vancomycin, beta-lactamase inhibitors, and carbapenems. Vancomycin is effective against methicillin-resistant Staphylococcus aureus while beta-
1) Colloid solutions such as plasma expanders maintain blood plasma volume more effectively and efficiently than crystalloid solutions which have a lower molecular weight and only remain in the plasma for a short time.
2) Penicillins and cephalosporins both work by inhibiting bacterial cell wall synthesis. Penicillins block cross-linking via inhibition of transpeptide enzymes while cephalosporins inhibit bacterial cell wall synthesis through inhibition of transpeptide enzymes.
3) Other classes of antibiotics that inhibit cell wall synthesis include vancomycin, beta-lactamase inhibitors, and carbapenems. Vancomycin is effective against methicillin-resistant Staphylococcus aureus while beta-
1) Colloid solutions such as plasma expanders maintain blood plasma volume more effectively and efficiently than crystalloid solutions which have a lower molecular weight and only remain in the plasma for a short time.
2) Penicillins and cephalosporins both work by inhibiting bacterial cell wall synthesis. Penicillins block cross-linking via inhibition of transpeptide enzymes while cephalosporins inhibit bacterial cell wall synthesis through inhibition of transpeptide enzymes.
3) Other classes of antibiotics that inhibit cell wall synthesis include vancomycin, beta-lactamase inhibitors, and carbapenems. Vancomycin is effective against methicillin-resistant Staphylococcus aureus while beta-